HCMSG - Hepatitis C Mentor & Support Group, Inc.
Search
  • About Us
    • Our Mission
    • Board of Directors
    • Medical Advisors
  • Resources
    • COVID-19
    • Harm Reduction
    • Hep C Risks
    • Hep C Facts & Stats
    • Medications and Treatments >
      • Patient Assistance Programs
    • Reading
    • Links
  • Programs/Training
    • The Circle Model >
      • THE CIRCLE Registration
      • Group and Facilitator Guide
      • Circle Sites
    • Hepatitis C Online Training
    • The Hepatitis C Education and Support Group Assistance Program
    • Healthcare Provider Training
  • Newsletter
  • Blog
  • Support Us
  • Contact Us

ACCESS TO HEPATITIS C THERAPY LISTENING SESSION WITH COMMUNITY STAKE HOLDERS

1/13/2015

0 Comments

 
January 12, 2015 • 0 comments • By Ronald Valdiserri, M.D., M.P.H., Deputy Assistant Secretary for Health, Infectious Diseases, and Director, Office of HIV/AIDS and Infectious Disease Policy, U.S. Department of Health and Human Services 
Dr. Ronald Valdiserri       http://blog.aids.gov/

Last month, the Department of Health and Human Services (HHS) convened a listening session on the important issue of access to curative treatment for hepatitis C virus infection. While the advent of more effective, second-generation direct-acting antivirals for the treatment of hepatitis C represents a tremendous scientific accomplishment and a potential public health triumph, community leaders and other stakeholders have raised serious concerns about barriers to treatment access. Many of these concerns had been expressed in a community sign-on letter sent to HHS Secretary Sylvia Burwell in early September 2014.

The listening session was hosted by the Office of the Assistant Secretary for Health and led by Dr. Wanda Jones, Principal Deputy Assistant Secretary for Health. The Acting Assistant Secretary for Health, Dr. Karen DeSalvo, was able to attend the initial portion of the meeting, which took place at the Humphrey Building on December 9, 2014. Twelve stakeholders representing healthcare providers, advocates, persons infected with HCV, representatives of professional organizations, and national leaders from a variety of disciplines joined federal leaders from across HHS to share information about HCV treatment access barriers and their impact on people living with chronic viral hepatitis.

The stakeholders who attended the meeting were especially concerned about restrictions on access to the new HCV treatments put in place by payers, which, in the stakeholders’ opinion, do not appear to be medically justified. Listed below are three examples of restrictions, shared by the community stakeholders:

  • Restrictions based on degree of liver fibrosis – some insurers and other payers require evidence of advanced liver fibrosis or cirrhosis before granting access to HCV treatment.
  • Restrictions based on alcohol and drug use/abuse – some insurers and other payers have instated various restrictions ranging from requirements of three months to one year of documented abstinence from alcohol and/or drug use as well as monitoring requirements during HCV therapy.
  • Restrictions based on the type of prescriber – many insurance plans and some other payers require specialists to prescribe HCV treatment which can limit access due to the limited number of specialists, especially in rural areas.
Although there are no easy or quick solutions to the issues raised during the discussion, hearing directly from our partners helps us better understand these complicated issues and informs our thinking about potential avenues to mitigate—or remove—the stated barriers. Shortly after the meeting, on Friday, December 19, 2014, the FDA approved a second all-oral treatment regimen for chronic HCV and more new therapeutic options are expected to be approved in 2015. These developments underscore that this is a quickly evolving arena. HHS remains committed to collaborating with all stakeholders, inside and outside of government, to implement the Viral Hepatitis Action Plan [PDF 2.01 MB], and to improve the diagnosis, treatment and prevention of viral hepatitis in the United States.

Related posts:

  1. Introducing a Viral Hepatitis Action Plan Stakeholders’ Workbook
  2. Expanding Roles and Opportunities for Nonfederal Stakeholders to Implement the Viral Hepatitis Action Plan
  3. Online Expert Advice for Clinicians Treating Hepatitis C Now Includes Section on When and For Whom to Initiate HCV Therapy
  4. Raising Awareness about Viral Hepatitis in the Hispanic Community
  5. Advancing the Viral Hepatitis Action Plan: Checking-In with Federal and Community Leaders
- See more at: http://blog.aids.gov/2015/01/access-to-hepatitis-c-therapy-listening-session-with-community-stakeholders.html#sthash.vttDKoBZ.dpufhttp://blog.aids.gov/
0 Comments

Your comment will be posted after it is approved.


Leave a Reply.

    Archives

    April 2021
    March 2021
    February 2021
    January 2021
    December 2020
    November 2020
    October 2020
    September 2020
    August 2020
    July 2020
    June 2020
    May 2020
    April 2020
    March 2020
    February 2020
    January 2020
    December 2019
    November 2019
    October 2019
    August 2019
    July 2019
    June 2019
    May 2019
    April 2019
    March 2019
    February 2019
    January 2019
    December 2018
    November 2018
    October 2018
    September 2018
    August 2018
    July 2018
    June 2018
    May 2018
    April 2018
    March 2018
    February 2018
    January 2018
    December 2017
    November 2017
    October 2017
    September 2017
    August 2017
    July 2017
    June 2017
    May 2017
    April 2017
    March 2017
    February 2017
    January 2017
    December 2016
    November 2016
    October 2016
    September 2016
    August 2016
    July 2016
    June 2016
    May 2016
    April 2016
    March 2016
    February 2016
    January 2016
    December 2015
    November 2015
    October 2015
    September 2015
    August 2015
    July 2015
    June 2015
    May 2015
    April 2015
    March 2015
    February 2015
    January 2015
    December 2014
    November 2014
    October 2014
    September 2014
    August 2014
    July 2014
    June 2014
    May 2014
    April 2014
    March 2014
    February 2014
    January 2014
    December 2013
    November 2013
    October 2013
    September 2013
    August 2013
    July 2013
    June 2013
    May 2013
    April 2013
    March 2013
    February 2013
    January 2013
    December 2012
    November 2012
    October 2012
    September 2012
    August 2012
    July 2012
    June 2012
    May 2012
    April 2012
    March 2012
    February 2012
    January 2012
    December 2011
    November 2011
    October 2011
    September 2011
    August 2011
    July 2011
    June 2011
    May 2011

    Categories

    All

    RSS Feed

Privacy Policy